Brancaccio John P insider trades
Brancaccio John P has filed 7 Form 4s with the SEC that we hold, for OKYO Pharma Ltd (OKYO) (Director), Cardiff Oncology, Inc. (CRDF) (Reporting owner) and Hepion Pharmaceuticals, Inc. (HEPA) (Chairman, Director). Across all of them we count 2 purchases worth $32.4K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($7.4K) and 0 sales ($0). The largest single trade was a purchase of 16,670 shares of OKYO Pharma Ltd worth $25.0K, dated 2023-09-15. The first filing on our record is dated 2022-03-10 and the latest 2026-08-07.
OKYO Pharma Ltd (OKYO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-09-15 | P, purchase reported on Form 4 | 16,670 | $25.0K | 2023-09-28 |
| 2026-07-21 | P, purchase reported on Form 4 | 5,000 | $7.4K | 2026-08-07 |
Cardiff Oncology, Inc. (CRDF)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Hepion Pharmaceuticals, Inc. (HEPA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1276551) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms